Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NAAA | Q02083 | 1/20 | 0.36 |
| ▸ | RARB | P10826 | 1/20 | 0.35 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.32 |
| ▸ | RAD52 | P43351 | 1/20 | 0.32 |
| ▸ | BLM | P54132 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.31 |
| ▸ | FAAH | O00519 | 1/20 | 0.31 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11030212 | 1.00 | NAAA (0.36) | NAAARARBNPSR1RAD52BLM | |
| SCHEMBL8575386 | 1.00 | NAAA (0.36) | NAAARARBNPSR1RAD52BLM | |
| SCHEMBL4412782 | 0.92 | NAAA (0.41) | NAAANPSR1RAD52MAPTMAPK1 | |
| SCHEMBL4407978 | 0.92 | NAAA (0.41) | NAAANPSR1RAD52MAPTMAPK1 | |
| SCHEMBL4408719 | 0.92 | NAAA (0.41) | NAAANPSR1RAD52MAPTMAPK1 | |
| SCHEMBL28647748 | 0.87 | CYP19A1 (0.41) | MAPK1CYP19A1 | |
| SCHEMBL28147990 | 0.86 | NAAA (0.35) | NAAARARBNPSR1RAD52MAPT | |
| SCHEMBL2131723 | 0.86 | NAAA (0.53) | NAAANPSR1RAD52LMNAMAPT | |
| SCHEMBL13734568 | 0.86 | NAAA (0.53) | NAAANPSR1RAD52LMNAMAPT | |
| SCHEMBL2130443 | 0.86 | NAAA (0.53) | NAAANPSR1RAD52LMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7204974-B2 | Stabilization of oxidation-sensitive or UV-sensitive active ingredients | BEIERSDORF AG (DE) | 2007-04-17 | — | — | US | claimed |
| US-20040258637-A1 | Stabilization of oxidation-sensitive or UV-sensitive active ingredients | BEIERSDORF AG | 2004-12-23 | — | — | US | claimed |
| EP-1141167-A4 | ELECTRICAL INSULATING FLUID | GREAT LAKES CHEMICAL EUROP (CH) | 2002-06-26 | — | — | EP | claimed |
| EP-1141167-A1 | ELECTRICAL INSULATING FLUID | Great Lakes Chemical (Europe) GmbH (CH) | 2001-10-10 | — | — | EP | claimed |
| WO-2000034409-A1 | ELECTRICAL INSULATING FLUID | GREAT LAKES CHEMICAL (EUROPE) GMBH (CH) | 2000-06-15 | — | — | WO | claimed |
| US-7875653-B2 | comprises a predominantly polar lipid phase and exhibits long-term stability; cosmetic | BEIERSDORF AG (DE) | 2011-01-25 | — | — | US | disclosed |
| US-20070092478-A1 | Emulsion comprising 1,2-alkanediols and polar oil components | BEIERSDORF AG (DE) | 2007-04-26 | — | — | US | disclosed |
| US-20070082033-A1 | Substrate containing lipids | BEIERSDORF AG (DE) | 2007-04-12 | — | — | US | disclosed |
| US-20050238610-A1 | Low-viscosity emulsions | BEIERSDORF AG | 2005-10-27 | — | — | US | disclosed |
| US-20050238605-A1 | Low-viscosity O/W emulsion | BEIERSDORF AG | 2005-10-27 | — | — | US | disclosed |
| EP-1141167-A4 | ELECTRICAL INSULATING FLUID | GREAT LAKES CHEMICAL EUROP (CH) | 2002-06-26 | — | — | EP | disclosed |
| EP-1141167-A1 | ELECTRICAL INSULATING FLUID | Great Lakes Chemical (Europe) GmbH (CH) | 2001-10-10 | — | — | EP | disclosed |
| WO-2000034409-A1 | ELECTRICAL INSULATING FLUID | GREAT LAKES CHEMICAL (EUROPE) GMBH (CH) | 2000-06-15 | — | — | WO | disclosed |
| US-5711939-A | IMPROVED SPREADABILITY, WATER VAPOR PERMEABILITY, ETHYLHEXYL ESTER OF ETHYLHEXANOIC ACID | DRAGOCO GERBERDING & CO., GMBH (DE) | 1998-01-27 | — | — | US | disclosed |
| EP-0116621-A1 | UTILISATION OF BRANCHED CHAIN CARBONIC ACID ESTERS WITH BRANCHED CHAIN ALCOHOLS AS COMPONENTS OF COSMETIC PRODUCTS. | DRAGOCO GERBERDING CO GMBH (DE) | 1984-08-29 | — | — | EP | disclosed |
| WO-1984000884-A1 | UTILISATION OF BRANCHED CHAIN CARBONIC ACID ESTERS WITH BRANCHED CHAIN ALCOHOLS AS COMPONENTS OF COSMETIC PRODUCTS | DRAGOCO GERBERDING CO GMBH (DE) | 1984-03-15 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040258637-A1 | Stabilization of oxidation-sensitive or UV-sensitive active ingredients | DEGS1, ACOX1, CUTA | NAAA 1262/4885RARB 716/4885NPSR1 3473/4885 |
| US-20070082033-A1 | Substrate containing lipids | LIPC, MGLL, LIPA | NAAA 206/4885RARB 3946/4885NPSR1 4304/4885 |
| US-20050238605-A1 | Low-viscosity O/W emulsion | POLH, DGAT2, POLQ | NAAA 2562/4885RARB 458/4885NPSR1 4066/4885 |
| US-20070092478-A1 | Emulsion comprising 1,2-alkanediols and polar oil components | DGAT2, DGAT1, MOGAT2 | NAAA 2220/4885RARB 2387/4885NPSR1 3621/4885 |
| US-20050238610-A1 | Low-viscosity emulsions | SGMS2, SGMS1, DEGS1 | NAAA 743/4885RARB 1281/4885NPSR1 4141/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.